AACC Booth Presentation: Risk Stratification in Heart Failure - The Role of Emerging Biomarkers
Originally presented July 27, 2014 in Chicago, Illinois.
David G. Grenache, PhD
Medical Director, Special Chemistry Laboratory, ARUP Laboratories
Co-Director, Electrophoresis and Manual Endocrinology Laboratory, ARUP Laboratories
Chief Medical Director, Clinical Chemistry, ARUP Laboratories
Associate Professor of Pathology, University of Utah School of Medicine
Dr. Grenache is the medical director of the Special Chemistry Laboratory, a co-director of the Electrophoresis and Manual Endocrinology Laboratory, and the chief medical director of clinical chemistry at ARUP Laboratories. He is an associate professor of pathology at the University of Utah School of Medicine. Dr. Grenache earned his PhD in biomedical sciences from Worcester Polytechnic Institute in Worcester, MA and completed his postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, MO. Dr. Grenache is a fellow in the National Academy of Clinical Biochemistry and is board certified in clinical chemistry by the American Board of Clinical Chemistry. His research interests include reproductive biochemistry and emerging biomarkers of disease.